Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Target date funds adjust asset allocations over time toward a chosen retirement year, simplifying diversification and rebalancing for many savers.
19,808 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Bitcoin steadies near $61,000 after bouncing from earlier lows as policymakers signal tighter liquidity. Analysts are...
A district tax office confrontation reveals how cash payments can slip through cracks. Explore what happened, how to ...
Bloom Energy skyrocketed over 248% in the first half of 2026, delivering eye-popping gains for early investors. This ...
This guide spotlights four housing markets long-term with strong, durable growth potential, plus five markets growing...
June data showed payroll gains stalled while prime-age participation fell, signaling hidden weakness beneath the surf...
A trusted USPS carrier exploited her route to lift sensitive mail, including checks and IDs. Learn how the scheme wor...
Rambus rides AI infrastructure tailwinds but keeps a neutral stance as investors weigh valuation against accelerating...
ethereum’s treasury boom company BitMine expands its ETH stake toward 5% of supply, signaling new dynamics for stakin...
Broadcom climbs about 5% to around $390 after Apple expands its multiyear chip deal. Intel and AMD drift lower as inv...
GM is navigating a tepid U.S. EV market, yet the company is pivoting toward energy storage and software. This article...
Investors are eyeing a nuclear energy stock with outsized upside as regulatory momentum and a growing project pipelin...